Chengming Fei
National Health Committee Key Laboratory Of Pediatric Hematology And Oncology
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Emapalumab in pediatric patients with high-grade cytokine release syndrome associated with CAR T-cell therapy.
Journal: Frontiers in immunology
Published: August 08, 2025
ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
Journal: International journal of oncology
Published: February 06, 2020
Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Journal: Cell death & disease
Published: December 07, 2017
Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway.
Journal: Cell death & disease
Published: November 02, 2017
Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway.
Journal: Oncotarget
Published: February 14, 2017
Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes.
Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 30, 2016
Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.
Journal: American journal of translational research
Published: March 17, 2016
Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.
Journal: American journal of translational research
Published: April 22, 2015
Last Updated: 09/26/2026